Fibrinogen Kyoto II new abnormal molecule replacement alpha leucine new case heterozygous dysfibrinogenemia amino acid replacement region fibrin alpha-chain woman bleeding problem one-stage prothrombin time partial thromboplastin time purified fibrinogen patient prolonged thrombin reptilase time Release fibrinopeptides normal polymerization fibrin monomers Sodium sulfate-polyacrylamide gel electrophoresis purified fibrinogen reduced condition abnormalities apparent molecular weights chains Reverse-phase high performance liquid chromatography HPLC lysylendopeptidase-cleaved alpha-chains decrease peptide normal amount appearance abnormal peptide peak peptides thrombin HPLC Amino acid sequence analysis abnormal peptide alpha second residue fibrin alpha-chain leucine synthetic peptide Gly-Pro-Arg-Pro thrombin- reptilase-induced fibrin aggregation Gly-Leu-Arg-Pro little inhibition conditions discovery abnormal fibrinogen findings alpha important part polymerization site fibrin alpha-chain propositus mother abnormal fibrinogen unique abnormal fibrinogen fibrinogen Kyoto II 